Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Option exercise President and CEO acquired 90,931 shares (option exercise)
  4. 8-K Event Results of operations
  5. 10-Q Report Quarterly Report
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 8-K Event Executive or director change
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change
  11. 3 Insider Initial Statement of Ownership
  12. 424B5 Offering Prospectus
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 8-K Event Results of operations
  15. 10-K Report Annual Report
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 8-K Event Executive or director change
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 15 of 41 · 801 filings